BRIEF published on 11/06/2025 at 13:05, 11 days 3 hours ago Moderna annonce un chiffre d'affaires d'un milliard de dollars au troisième trimestre 2025, malgré des prévisions financières revues à la baisse pour 2025. Résultats Financiers Moderna Baisse Des Revenus Vaccin Contre Le Covid-19 Efficacité En Matière De Coûts
BRIEF published on 11/06/2025 at 13:05, 11 days 3 hours ago Moderna Reports $1 Billion Revenue in Q3 2025 Amidst Narrowed 2025 Financial Projections Financial Results COVID-19 Vaccine Revenue Decline Moderna Cost Efficiency
PRESS RELEASE published on 11/06/2025 at 13:00, 11 days 3 hours ago Moderna Reports Third Quarter 2025 Financial Results and Provides Business Updates Moderna, Inc. reports Q3 revenue of $1.0B with a net loss of $(0.2)B. Narrows 2025 revenue range and improves operating expenses. Business updates and financial results detailed Financial Results Moderna Inc. Business Updates Operating Expenses Q3 Revenue
BRIEF published on 11/03/2025 at 13:05, 14 days 3 hours ago Moderna Initiates Phase 1/2 Trial for Multiple Myeloma Therapy Moderna Multiple Myeloma Phase 1/2 Study MRNA-2808 T-Cell Engager
BRIEF published on 11/03/2025 at 13:05, 14 days 3 hours ago Moderna lance un essai de phase 1/2 pour un traitement du myélome multiple Moderna Myélome Multiple Étude De Phase 1/2 ARNm-2808 Engager Les Lymphocytes T
PRESS RELEASE published on 11/03/2025 at 13:00, 14 days 3 hours ago Moderna Announces First Patient Dosed in Phase 1/2 Study of Investigational T-Cell Engager for Multiple Myeloma Moderna doses first patient with mRNA-2808 in Phase 1/2 study for multiple myeloma. Targets validated myeloma-associated antigens to combat resistance mechanisms Moderna Multiple Myeloma Phase 1/2 Study MRNA-2808 T-Cell Engager
BRIEF published on 10/23/2025 at 20:47, 24 days 20 hours ago Moderna Recognized as Top Employer for Eleventh Year in a Row Innovation Moderna MRNA Top Employer MNEXSPIKE
BRIEF published on 10/23/2025 at 20:47, 24 days 20 hours ago Moderna reconnue comme l'un des meilleurs employeurs pour la onzième année consécutive Innovation Moderne ARNm Meilleur Employeur MNEXSPIKE
PRESS RELEASE published on 10/23/2025 at 20:42, 24 days 20 hours ago Moderna Named a Top Employer by Science for Eleventh Consecutive Year Moderna, Inc. named a top employer in biopharmaceutical industry by Science for 2025. Recognized for innovation, commitment, and culture Moderna Inc. Biopharmaceutical Industry MRNA Technology Top Employer Science Survey
BRIEF published on 10/23/2025 at 13:05, 25 days 3 hours ago Moderna organise un événement pour les investisseurs le 20 novembre 2025 Webcast Moderne Événement Pour Les Investisseurs Technologie De L'ARNm Journée Des Analystes
Published on 11/17/2025 at 16:10, 40 minutes ago GPO Plus, Inc. Announces 20% Sequential Quarterly Revenue Growth and Accelerates Near-Term Expansion Initiatives
Published on 11/17/2025 at 15:37, 1 hour 13 minutes ago Gold Terra is Upsizing Its Private Placement from C$6.3 Million to C$7.0 Million
Published on 11/17/2025 at 14:30, 2 hours 20 minutes ago Kidoz Inc. to Publish Q3 2025 Financial Results on Thursday November 20th, 2025
Published on 11/17/2025 at 14:30, 2 hours 20 minutes ago NanoViricides, Inc. Has Filed its Quarterly Report - Subsequent Raise Has Fortified Fiscal Position
Published on 11/17/2025 at 14:15, 2 hours 35 minutes ago Rockhaven Reports Multiple High-Grade Vein Exposures at its Klaza Gold-Silver Project, Yukon
Published on 11/17/2025 at 16:35, 15 minutes ago Nomad eSIM Announces Strong Growth with Expanded Enterprise and Consumer Offerings
Published on 11/17/2025 at 16:10, 40 minutes ago DigiKey to Highlight Innovative Automation Products and Industry-Leading Suppliers at SPS 2025
Published on 11/17/2025 at 16:05, 45 minutes ago SwitchBot Launches the New Presence Sensor with mmWave Radar
Published on 11/17/2025 at 15:19, 1 hour 31 minutes ago Original-Research: Lisata Therapeutics Inc (von First Berlin Equity Research GmbH): BUY
Published on 11/16/2025 at 20:26, 20 hours 24 minutes ago Déclaration des transactions sur actions propres réalisées du 27 octobre au 31 octobre 2025
Published on 11/16/2025 at 20:26, 20 hours 24 minutes ago Disclosure of trading in own shares between October 27th and October 31st, 2025
Published on 11/14/2025 at 16:58, 2 days 23 hours ago Résultats trimestriels au 30 septembre 2025 - ANR par action en hausse de +2,14 % depuis le 1er janvier 2025 - Fonds propres consolidés : 698 M€
Published on 11/13/2025 at 18:30, 3 days 22 hours ago RÉSULTATS DE L’ASSEMBLÉE GÉNÉRALE MIXTE DU 13 NOVEMBRE 2025
Published on 11/13/2025 at 18:30, 3 days 22 hours ago RESULTS OF THE COMBINED GENERAL MEETING ON NOVEMBER 13, 2025
